Barriers and facilitators to cell saver use in damage control surgery
Transfusion · 2026-08 · 66 (8) · 1536-1551
DOI: 10.1111/trf.70274 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transfusion, online erschienen am 18.05.2026. Verfasst von B P Satter und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Alrijne Medical Center, Leiderdorp, The Netherlands. Hauptthemen laut MEDLINE: Operative Blood Salvage, Blood Transfusion, Autologous. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Cell savers reduce the use of allogeneic blood and can serve as an important adjunct during blood shortages. This study investigates the user perspective on cell saver (CS) use during damage control surgery (DCS) in the Netherlands. Study Design and Methods A survey was conducted amongst trauma surgeons and anesthesiologists from Dutch level 1 trauma centers and military‐affiliated hospitals. The survey assessed the perceived usability and usefulness of CS in DCS, addressing factors such as logistics, training, experience, (contra)indications, and perceived suitability of CS or reinfusion of unwashed salvaged blood during blood shortages. Responses were analyzed using a five‐point scale.
Results
195 of the 707 (28%) invited clinicians completed the survey. Most rated CS as very useful or essential during DCS (trauma surgeons: 58%, anesthesiologists: 64%). Staff (90%) and disposables (84%) were reportedly available, but reported concerns included CS being time‐consuming (trauma: 23%, anesthesia: 40%), contamination risk from gastrointestinal injuries (trauma: 37%, anesthesia: 21%), and insufficient suction power (trauma: 19%, anesthesia: 10%). During blood shortages, most respondents considered CS suitable for DCS (trauma: 54%, anesthesia: 63%), but fewer supported reinfusion of unwashed salvaged blood (trauma: 62%, anesthesia: 25%).
Discussion
The routine use of CS during DCS may be hampered by practical and clinical barriers, such as time constraints, limited training, and the risk of complications. Targeting these areas and correlating these findings to clinical outcomes may increase the use of autologous blood transfusion techniques.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Surgery, Alrijne Medical Center, Leiderdorp, The Netherlands.
- Trauma Research Unit Department of Surgery, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
- Military Blood Bank, Ministry of Defense, Utrecht, The Netherlands.
- Defense Healthcare Organization, Ministry of Defense, Utrecht, The Netherlands.
- Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands.
ORCID-Profile: B P Satter, Robert A van der Horst, Tim W H Rijnhout, Femke Noorman, Boudewijn L S Borger van der Burg, Oscar J F van Waes, Michael H J Verhofstad, Rigo Hoencamp
Zitieren
APA
Satter, B. P., van der Horst, R. A., Rijnhout, T. W. H., Noorman, F., van der Burg, B. L. S. B., van Waes, O. J. F., Verhofstad, M. H. J., & Hoencamp, R. (2026). Barriers and facilitators to cell saver use in damage control surgery. Transfusion, 66(8), 1536-1551. https://doi.org/10.1111/trf.70274
Vancouver
Satter BP, van der Horst RA, Rijnhout TWH, Noorman F, van der Burg BLSB, van Waes OJF, et al. Barriers and facilitators to cell saver use in damage control surgery. Transfusion. 2026;66(8):1536-1551. doi:10.1111/trf.70274
BibTeX
@article{Satter2026,
author = {Satter, B P and van der Horst, Robert A and Rijnhout, Tim W H and Noorman, Femke and van der Burg, Boudewijn L S Borger and van Waes, Oscar J F and Verhofstad, Michael H J and Hoencamp, Rigo},
title = {Barriers and facilitators to cell saver use in damage control surgery},
journal = {Transfusion},
year = {2026},
volume = {66},
number = {8},
pages = {1536--1551},
doi = {10.1111/trf.70274}
}
EUVIMED